MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) is developing a voice analysis platform that uses artificial intelligence to detect drug and alcohol impairment from short speech samples. The technology, trained on more than 50 million data points and analyzing over 140 acoustic markers, offers a non-invasive alternative to traditional breath, saliva, urine and laboratory-based testing. The platform is designed to deliver real-time impairment assessments through Edge AI kiosks, with initial field testing planned in 2026.
The company's initial commercial focus is on South American mining operations, where large-scale workforce screening presents significant safety and logistical challenges. The global alcohol and drug testing devices market is projected to grow from approximately $2.5 billion in 2025 to $4.2 billion by 2033, according to the source article. MindBio sees opportunities to expand its platform into aviation, construction, transportation, law enforcement, call centers and healthcare, leveraging its proprietary research to address the increasing demand for faster, scalable workplace impairment detection.
MindBio's AI prediction model uses over 50 million data points to predict alcohol intoxication with remarkable accuracy, just by using the human voice. The company is developing an enterprise platform including Edge-AI kiosks integrating bespoke hardware and software for the detection of drug and alcohol intoxication using the human voice and AI in a range of enterprise environments including the mining industry, aviation, construction and law enforcement.
For more details on the technology and its applications, the full article is available at https://ibn.fm/Gw5Fa. The latest news and updates relating to MBQIF are available in the company’s newsroom at https://ibn.fm/MBQIF.
This development is significant because it introduces a scalable, non-invasive method for real-time impairment detection that could address safety and efficiency challenges across multiple industries. As the market for testing devices expands, MindBio's platform could become a key solution for employers and law enforcement agencies seeking faster and more accurate screening tools.
